Unknown

Dataset Information

0

EDNRB isoform 3 confers Temozolomide resistance in A375 melanoma cells by modulating membrane potential, reactive oxygen species and mitochondrial Ca2.


ABSTRACT: Background:The role of endothelin receptor type B (EDNRB) isoform 3 involved in Temozolomide (TMZ)-induced melanoma cell death has not yet been elucidated. Methods:The subcellular localization of EDNRB isoform 3 was determined by confocal and immunoblotting assays. Silencing EDNRB isoform 3 was performed by CRISPR/Cas9. Apoptosis was assessed by annexin V/propium iodide staining and caspases 3/7/9 activity. Mitochondrial membrane potential, reactive oxygen species and mitochondrial Ca2+ were measured by flow cytometry. Apoptosis protein array was applied. Results:Confocal and immunoblot analyses indicate mitochondrial localization of EDNRB isoform 3 and the first N-terminal (1-22) amino acids are sufficient for its mitochondrial targeting. EDNRB isoform 3 depleted A375 cells significantly confers chemoresistance with mitochondrial depolarization, reduced reactive oxygen species, enhanced mitochondrial Ca2+ uptake and decreased caspase 9 activation. Additionally, apoptosis array shows that lack of EDNRB isoform 3 has relatively lower expression of phosphorylation of p53 at S392 and a slightly higher expression of Paraoxonase 2. Conclusion:Our findings raise the possibility of targeting EDNRB isoform 3 as a new therapeutic strategy in combination with TMZ for melanoma treatment.

SUBMITTER: Chen YS 

PROVIDER: S-EPMC6689146 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

EDNRB isoform 3 confers Temozolomide resistance in A375 melanoma cells by modulating membrane potential, reactive oxygen species and mitochondrial Ca<sup>2</sup>.

Chen Yun Shan YS   Liu Fen F   Luo Yi Hong YH   Fan Yue Y   Xu Fang Gui FG   Li Pin P   Zhou Bei B   Pan Xiu Yu XY   Wang Chi Chiu CC   Cui Long L  

Cancer management and research 20190805


<h4>Background</h4>The role of endothelin receptor type B (EDNRB) isoform 3 involved in Temozolomide (TMZ)-induced melanoma cell death has not yet been elucidated.<h4>Methods</h4>The subcellular localization of EDNRB isoform 3 was determined by confocal and immunoblotting assays. Silencing EDNRB isoform 3 was performed by CRISPR/Cas9. Apoptosis was assessed by annexin V/propium iodide staining and caspases 3/7/9 activity. Mitochondrial membrane potential, reactive oxygen species and mitochondria  ...[more]

Similar Datasets

| S-EPMC6843202 | biostudies-literature
| S-EPMC7738866 | biostudies-literature
| S-EPMC8216240 | biostudies-literature
| S-EPMC7949085 | biostudies-literature
| S-EPMC6802611 | biostudies-literature
| S-EPMC3127936 | biostudies-literature
| S-EPMC6414521 | biostudies-literature
| S-EPMC7987452 | biostudies-literature
| S-EPMC7031409 | biostudies-literature
| S-EPMC7547442 | biostudies-literature